MENU
+Compare
PBSV
Stock ticker: OTC
AS OF
Jun 27 closing price
Price
$0.51
Change
-$0.09 (-15.00%)
Capitalization
24.67M

PBSV Pharma-Bio Serv, Inc. Forecast, Technical & Fundamental Analysis

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm... Show more

PBSV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PBSV with price predictions
Jun 27, 2025

Aroon Indicator for PBSV shows an upward move is likely

PBSV's Aroon Indicator triggered a bullish signal on June 09, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 101 similar instances where the Aroon Indicator showed a similar pattern. In of the 101 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PBSV just turned positive on June 23, 2025. Looking at past instances where PBSV's MACD turned positive, the stock continued to rise in of 76 cases over the following month. The odds of a continued upward trend are .

PBSV moved above its 50-day moving average on May 29, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PBSV crossed bullishly above the 50-day moving average on June 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PBSV moved out of overbought territory on May 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator moved out of overbought territory. In of the 13 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PBSV as a result. In of 152 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

PBSV broke above its upper Bollinger Band on June 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBSV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.319) is normal, around the industry mean (31.808). P/E Ratio (16.077) is within average values for comparable stocks, (163.898). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.732). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (1.137) is also within normal values, averaging (61.976).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBSV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
PBSV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PBSV is expected to report earnings to 2 cents per share on September 10

Pharma-Bio Serv, Inc. PBSV Stock Earnings Reports
Q3'25
Est.
$0.03
Q2'25
Est.
$0.03
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.04
The last earnings report on June 16 showed earnings per share of 2 cents, meeting the estimate of 2 cents. With 5.00K shares outstanding, the current market capitalization sits at 24.66M.
A.I.Advisor
published Dividends

PBSV paid dividends on March 20, 2025

Pharma-Bio Serv, Inc. PBSV Stock Dividends
А quarterly dividend of $0.08 per share was paid with a record date of March 20, 2025, and an ex-dividend date of February 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
No. 6 Road 696
Phone
+1 787 278-2709
Employees
140
Web
https://www.pharmabioserv.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCPNF13.03N/A
N/A
Olympus Corp.
ROIUF0.07N/A
N/A
Route1 Inc.
CELJF7.95N/A
N/A
Cellcom Israel, Ltd.
ALBKF3.25N/A
N/A
Alpha Services and Holdings SA
SNZZF0.53N/A
N/A
Senzime AB

PBSV and Stocks

Correlation & Price change

A.I.dvisor tells us that PBSV and OTEX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBSV and OTEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBSV
1D Price
Change %
PBSV100%
-15.00%
OTEX - PBSV
20%
Poorly correlated
-0.66%
PONGF - PBSV
10%
Poorly correlated
+18.42%
PMCUF - PBSV
7%
Poorly correlated
+2.29%
OTGLY - PBSV
6%
Poorly correlated
-0.65%
PANHF - PBSV
0%
Poorly correlated
N/A
More